openPR Logo
Press release

Androgen deprivation therapy Market to Witness a Geometric Progression between 2020 and 2030

10-21-2020 12:14 PM CET | Health & Medicine

Press release from: Persistence Market Research

Androgen deprivation therapy is a hormone therapy of prostate cancer in males, by depriving the excess amount of androgen. Androgen is a sex hormone produced in the testes and adrenalin gland in the form of testosterone and dihydrotestosterone. According to the World Health Organization (WHO), prostate cancer is the fourth leading cancer, with 1.3 million global cases. Androgen deprivation therapy comprises the deprivation androgen to curb its detrimental effects such as promoting the cancer cell growth in the early stages and modulate androgen functions. Androgen deprivation therapy is also coupled with external beam radiotherapy to treat intermediate and high-risk prostate cancer. The global androgen deprivation therapy market is poised to grow lucratively with the rising cases of prostate cancers, also the advancing healthcare and research to fuel the market growth further. Coronavirus pandemic has also shaped the global androgen deprivation therapy market. It has been found in a study that patients of prostate cancer who received the androgen deprivation therapy were at lower risk of coronavirus. Therefore, these findings indicate that the androgen deprivation therapy market has propelled in the coronavirus crisis.

To remain ‘ahead’ of your competitors, request for a sample here@ https://www.persistencemarketresearch.com/samples/31996

Androgen Deprivation Therapy Market: Drivers and Restraints
The growth of the global androgen deprivation therapy market is driven by the rising cases and deaths by prostate cancer, innovative technologies, advancing healthcare expenditure and facilities, increasing global awareness and demand for better treatment. The R&D bodies are actively dwelling to develop novel androgen deprivation therapy for cancer. The approval of new drugs have also propelled the androgen deprivation therapy market growth. However, the market growth is constrained by the resistance developed during the treatments, side effects such as hot flashes, erectile dysfunction, low bone density, insulin resistance etc. Androgen deprivation therapy is ineffective for hormone-refractory prostate cancer. The high expenses and poor reimbursement of treatment expenses hinder the market growth. Although, the overall global androgen deprivation therapy market is anticipated to grow further due to the increasing cases of prostate cancer, improving R&D and healthcare facilities.

Request For Table of Content (TOC) @ https://www.persistencemarketresearch.com/toc/31996

Androgen Deprivation Therapy Market: Segmentation
The global androgen deprivation therapy market is segmented into drug class, route of administration, end-user and region.
By drug class, the global androgen deprivation therapy market is further segmented into
• Luteinizing Hormone-Releasing Hormone (LHRH) agonists
• LHRH antagonists
• Antiandrogens
• Others
By route of administration, the global androgen deprivation therapy market is further segmented into
• Injectable
• Oral
By end-users, the global androgen deprivation therapy market is further segmented into
• Hospitals
• Clinics
• Others
Androgen Deprivation Therapy Market: Overview
The global androgen deprivation therapy market is expected to grow lucratively with the rising cases of prostate cancer, advancing R&D and healthcare. By drug type, the luteinizing hormone-releasing hormone (LHRH) rules the segment due to its massive application into prostate cancer therapy, without causing short term boost of testosterone production during the treatment. By route of administration, injectable dominates the segment due to their high efficacy and bioavailability. By end-user, the hospitals rule the segment with its advanced facilities and experienced medical professionals.
Androgen Deprivation Therapy Market: Regional Outlook
North America leads the global androgen deprivation therapy market with the high prevalence of prostate cancer, massive R&D investments, advanced healthcare expenditure and development novel immunotherapies. Europe holds the second largest global androgen deprivation therapy market with its advanced healthcare facilities and massive research investments. Asia-Pacific androgen deprivation therapy market is the fastest emerging and is driven by the increasing burden of prostate cancer, increasing awareness, and government aids, improving healthcare facilities and advancing research. Latin America androgen deprivation therapy market is growing with the increasing prevalence of prostate cancer, progressing research and healthcare facilities. The Middle East & Africa androgen deprivation therapy market is least lucrative due to the lack of awareness and underdeveloped healthcare infrastructure.
Androgen Deprivation Therapy Market: Key Players
The key players of the global androgen deprivation therapy market include Allergan plc, Amgen, Bayer, AstraZeneca, Johnson & Johnson, Pfizer, Sanofi and others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.
The report covers exhaust analysis on:
• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Indication
• Value Chain
Regional analysis includes:
• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Europe (Germany, U.K, France, Italy, Spain)
• South Asia (India, ASEAN Countries)
• East Asia (Japan, China & South Korea)
• Oceania (Australia & New Zealand)
• Middle East and Africa (GCC Countries, South Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

You can access Full report here @ https://www.persistencemarketresearch.com/checkout/31996

Contact Us:
305 Broadway
7th Floor
New York City, NY 10007
United States
USA - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com

Persistence Market Research (PMR) is an innovative and specialized publisher of market intelligence reports and consulting services. Prompt delivery, in-depth research, and high quality are the sacrosanct principles of PMR.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Androgen deprivation therapy Market to Witness a Geometric Progression between 2020 and 2030 here

News-ID: 2166723 • Views: 288

More Releases from Persistence Market Research

Plastic Waste Management Market expanding at a CAGR of 3.9% over the forecast pe …
PMR delivers key insights on the global plastic waste management market in its revised report titled ‘Plastic Waste Management Market: Global Industry Analysis 2013 – 2017 and Forecast, 2018 – 2026.’ The long-term outlook on the global plastic waste management market will remain positive with the plastic waste management market value expected to increase at a CAGR of 3.9% during the forecast period 2018 – 2026. According to the resin
North America to Stay Exponentially Tuned in the Anti Obesity Prescription Marke …
Globally, obesity is a public health problem. Obesity is a genetic and chronic metabolic disease involving accumulation of excessive or abnormal fat in the body. It contributes to risk of chronic conditions such as cancer, hypertension, cardiovascular diseases, diabetics, obstructive sleep apnea, ventilatory failure, renal failure and asthma. According to a World Health Organization (WHO) report published in 2014, around 3.4 million adults in the world die each year due
Europe to hold The major Piece of Cake in the Syringes Needles Market between 20 …
Syringes and needles are sterile devices used to inject solutions into the body. Syringes and needles are also used to isolate various types of body fluids, such as tissues from swollen joints and blood from veins. A syringe is made up of glass or plastic and shaped like a cylinder with a plunger at one end and an opening that attaches to a needle. Needles are hollow metal tube with
North America to Stand in a Better Stead in the Laparoscopy Surgical Clamp marke …
Laparoscopy surgical clamp, alternatively known as forceps, is the surgical device designed to compress, or closely hold the stomach during surgery. Laparoscopy is the most common surgical technique utilized over the globe. Laparoscopic surgery technique involves the use of minimally invasive procedure to access the body parts. It is specially designed equipment that enables the surgeon to perform surgery without scalpel based technique or open access. Laparoscopic surgery involves the

All 5 Releases


More Releases for Androgen

Androgen Deprivation Therapy Market, Industry Share, Trends, Growth, Future Pros …
Androgen deprivation therapy (ADT), also known as androgen suppression therapy, is administered to men with prostate cancer. The pancreas can provide treatment for advanced and metastatic disease by providing ADT as an androgen-dependent organ. ADT is also used in conjunction with external beam radiation therapy (EBRT) to improve response to radiation in patients with moderate to high risk prostate cancer. It is estimated that about 40% of patients diagnosed with
Androgen Antagonist Market 2020 Covid-19 impact analysis– Tokai Pharmaceutical …
Androgen Antagonist -Pipeline Insight, 2020 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Androgen Antagonist Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has
Androgen Deprivation Therapy (ADT) Market 2018 Unique Research Methodologies Wit …
Androgens are male sex hormones responsible for masculine characteristics such ad muscular build, deeper voice, and facial hair. Most of the androgens are produced in testes and their two most common types are dihydrotestosterone (DHT) and testosterone. Along with normal functions, androgens also contribute to prostate cancer cell growth, especially during early stages of the cancer. Androgen deprivation therapy, also called androgen suppression therapy, is used either to reduce the
Global (United States, European Union and China) Androgen Replacement Therapy Ma …
Market Research Report Store offers a latest published report on Androgen Replacement Therapy Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/621294/global-united-states-european-union-china   In 2019, the market size of
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer …
Prostate cancer occurs when cells in prostate glands grow uncontrollably. Prostate is an exocrine gland that makes the fluid part of semen and lie below the bladder in front of the rectum. As per the National Institute of Health (NIH), 10.7% of all new cases of cancer in the U.S. are of prostate cancer. Download the sample report @ https://www.pharmaproff.com/request-sample/1137 Moreover, according to the National Cancer Institute, prostate cancer is the
Global Androgen Replacement Therapy Sales Market Share, Growth, Size, Trends and …
To study the market for Androgen Replacement Therapy market in a precise manner, Market Research Hub (MRH) has included a new research report. The report is titled “Global Androgen Replacement Therapy Sales Market”, which enlightens the readers about the market share as well as growth rate during the period 2018-2025. The research study estimates that the Androgen Replacement sales market would be rising with a positive CAGR during the same